
zzso zzso zzso are vascular tumors that represent attractive targets for zzso zzso In this Review, we present the rationale and clinical trial evidence for targeting zzso in zzso focusing predominantly on agents that target vascular zzso growth factor zzso and its zzso zzso a humanized zzso zzso against zzso was recently approved by the zzso for treatment of zzso zzso zzso zzso zzso survival and controls zzso zzso but its effects on overall survival remain to be zzso Other zzso of zzso zzso receptors and other zzso signaling pathways are being zzso zzso therapies are well zzso although potentially serious adverse events can occasionally occur, and resistance to zzso therapy inevitably zzso zzso of resistance include zzso of alternative zzso zzso and increased zzso tumor zzso zzso progression on zzso agents is a challenging problem for which no effective salvage therapy has been zzso Combining these agents with radiation therapy, zzso chemotherapy, other targeted molecular agents, or zzso therapies could be zzso The international Response Assessment in zzso Working Group has developed consensus treatment response criteria for zzso that account for the complex effects of zzso zzso 

